Insider Transactions in Q4 2024 at Alnylam Pharmaceuticals, Inc. (ALNY)
Insider Transaction List (Q4 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 12
2024
|
Pushkal Garg CMO & EVP Dev & Med Affairs |
SELL
Open market or private sale
|
Direct |
1,752
-1.49%
|
$439,752
$251.62 P/Share
|
|
Nov 27
2024
|
Kevin Joseph Fitzgerald CSO & EVP, Head of Research |
SELL
Open market or private sale
|
Direct |
1,531
-2.75%
|
$385,812
$252.59 P/Share
|
|
Nov 26
2024
|
Kevin Joseph Fitzgerald CSO & EVP, Head of Research |
SELL
Open market or private sale
|
Direct |
1,469
-1.9%
|
$367,250
$250.35 P/Share
|
|
Nov 26
2024
|
Tolga Tanguler EVP, Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
1,469
-2.07%
|
$367,250
$250.35 P/Share
|
|
Nov 26
2024
|
Jeffrey V. Poulton EVP, Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
1,682
-1.06%
|
$420,500
$250.35 P/Share
|
|
Nov 26
2024
|
Pushkal Garg CMO & EVP Dev & Med Affairs |
SELL
Open market or private sale
|
Direct |
1,682
-1.81%
|
$420,500
$250.35 P/Share
|
|
Nov 26
2024
|
Yvonne Greenstreet Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
5,219
-1.27%
|
$1,304,750
$250.35 P/Share
|
|
Nov 25
2024
|
Kevin Joseph Fitzgerald CSO & EVP, Head of Research |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+15.89%
|
-
|
|
Nov 25
2024
|
Tolga Tanguler EVP, Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,000
+16.99%
|
-
|
|
Nov 25
2024
|
Jeffrey V. Poulton EVP, Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
3,434
+9.6%
|
-
|
|
Nov 25
2024
|
Pushkal Garg CMO & EVP Dev & Med Affairs |
BUY
Grant, award, or other acquisition
|
Direct |
3,434
+15.21%
|
-
|
|
Nov 25
2024
|
Yvonne Greenstreet Chief Executive Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,658
+11.25%
|
-
|
|
Oct 08
2024
|
Pushkal Garg CMO & EVP Dev & Med Affairs |
BUY
Grant, award, or other acquisition
|
Direct |
96
+0.61%
|
-
|
|
Oct 01
2024
|
Robert W. Hesslein EVP, CLO and Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
7,245
+50.0%
|
-
|